Publikationen 2001

  • requency of mitochondrial transfer RNA mutations and deletions in 225 patients presenting with respiratory chain deficiencies. (J Med Genet)
    Jaksch M, Kleinle S, Scharfe C, Klopstock T, Pongratz D, Müller-Höcker J, Gerbitz KD, Liechti-Gallati S, Lochmuller H, Horvath R
  • Deactivation and desensitization of mouse embryonic- and adult-type nicotinic receptor channel currents. (Neurosci Lett)
    Jahn K, Mohammadi B, Krampfl K, Abicht A, Lochmüller H, Bufler J
  • [Paraneoplastic diseases of the central nervous system from the neurologic and internal medicine viewpoint] (Internist (Berl))
    Schröder M, Pongratz D
  • [Therapy of polyneuropathies. Causal and symptomatic] (MMW Fortschr Med)
    Müller-Felber W
  • [What helps in back pain? Guideline for symptomatic therapy] (MMW Fortschr Med)
    Pongratz D, Späth M
  • [Fibromyalgia] (Fortschr Neurol Psychiatr)
    Pongratz D, Späth M
  • Effects of heat and cold application on turns and amplitude in surface EMG. (Electromyogr Clin Neurophysiol)
    Krause KH, Magyarosy I, Gall H, Ernst E, Pongratz D, Schoeps P
  • [New insights in pathogenesis and therapy of sporadic inclusion body myositis (s-IBM)] (Nervenarzt)
    Walter MC, Lochmüller H, Schlotter B, Reilich P, Müller-Felber W, Pongratz D
  • [5-HT3 receptor antagonists as a new therapeutic principle in rheumatology?] (Z Rheumatol)
    Pongratz D
  • Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. (Int J Clin Pharmacol Res)
    Färber L, Stratz TH, Brückle W, Späth M, Pongratz D, Lautenschläger J, Kötter I, Zöller B, Peter HH, Neeck G, Welzel D, Müller W,
  • 64th ENMC International Workshop: therapeutic approaches to dermatomyositis, polymyositis, and inclusion body myositis29-31 January 1999, Naarden, The Netherlands. (Neuromuscul Disord)
    Müller-Felber W, Pongratz D, Reimers C